Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Adherence news

Show

From To
Only three in 10 Americans have HIV under control: government report

Just 30 percent of Americans living with HIV have the virus in check, putting others at risk of infection, U.S. health officials said yesterday. The report by the U.S. Centers for Disease Control and Prevention (CDC) found that 840,000 of the 1.2 million people infected with HIV in 2011 were not consistently taking anti-HIV drugs that keep the virus suppressed at very low levels.

Published
26 November 2014
From
Reuters
Positive response to 'gift tokens for undetectable viral load' trial

A US study presented at last month’s HIV Research for Prevention conference found generally positive responses among people with HIV and clinic staff to a trial that

Published
24 November 2014
By
Gus Cairns
The Guy Who Delivers HIV Medicine On His Bicycle

Sizwe Nzima was a high school student in Cape Town, South Africa, when he would pick up the medicine for his HIV-positive grandparents, who had difficulty traveling to the clinic themselves. Because of the long lines, Nzima usually waited hours and often made multiple trips to the clinic before and after school. So there he was, sitting on a hard wooden bench at the clinic one day about four years ago, when he had an idea: Why not start an HIV medicine delivery service?

Published
18 November 2014
From
NPR (blog)
Innovation in fixed-dose combos: HIV/AIDS therapeutics edition

FDC drug development is evolving rapidly as the industry gains experience in manufacturing them and ushering them through the review process. The laws have changed towards a more favorable marketing climate. And finally, it is clear that FDCs are more than a way to improve adherence—though that will always be a prominent consideration. FDCs can shift the standard of care towards a more tolerable, patient-friendly, value-oriented approach to treatment, and in the final analysis, that approach to development bodes well for companies, payers, and most importantly, patients.

Published
07 November 2014
From
BioPharma Dive
Factors Associated With 10 Years of Continuous Viral Load Suppression on HIV Treatment

There is no magic formula for achieving 10 years of continuous viral load suppression on antiretroviral therapy in people living with HIV -- even perfect adherence didn't improve the chances of continuously suppressed viral loads, according to a poster analysis of the U.S. Military HIV Natural History Study (NHS) cohort presented at IDWeek 2014 in Philadelphia.

Published
29 October 2014
From
TheBody.com
Behavioural and financial incentives may improve HIV treatment outcomes

While making medications free can remove barriers to access for individuals who cannot pay for treatment, data suggest that for most people accessing care in industrialised countries, "making

Published
23 October 2014
By
Theo Smart
IDWeek 2014: Behavioral and Financial Incentives May Improve HIV Treatment Outcomes

While making medications free can remove barriers to access for individuals who cannot pay for treatment, data suggest that for most people accessing care in industrialized countries, "making medications available for free or low cost will not solve problems with medication non-adherence," according to a presentation by Kevin Volpp from the University of Pennsylvania last week at IDWeek 2014 in Philadelphia.

Published
16 October 2014
From
HIVandHepatitis.com
Targeted adherence measures and viral load monitoring needed to improve retention in South African ART programme

Of the people living with HIV in South Africa who are eligible to start antiretroviral therapy (ART), only 57% are in care and only 37% of

Published
16 October 2014
By
Lesley Odendal
Why I Refused, Then Later Embraced, HIV Treatment

"On good days, adhering to my pill is a positive affirmation of my life, an exercise in self-love. On bad days, it's just a pill I need to swallow, not terribly bitter but as mildly annoying as having to shave or tie my shoelaces every day. It's yet another thing to add to my list of things, but I do it anyway." Josh Kruger on his ambiguous relationship to HIV treatment.

Published
01 October 2014
From
TheBody.com
Exclusive: India set to run out of critical free drug for HIV/AIDS program

India could run out of a critical medicine in its free HIV/AIDS drugs program in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month.

Published
01 October 2014
From
Reuters
← First12345...31Next →

Filter by country